Detailed View
MRK - Merck & Company, Inc.
Latest filing: 2026-03-31 | Reporting: gaap
Market Cap
317,100,261,376
Adj EBIT (TTM)
9,745,000,000
Enterprise Value
360,568,261,376
Last Price
128.39
Earnings Yield
2.70%
Return on Capital
17.91%
Capital
54,414,000,000
1Y Price Chart
Last Price: -
1Y Change: -
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-03-31 | 10-Q | 2026 | 16,286,000,000 | -4,243,000,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 16,400,000,000 | 2,963,000,000 |
| 2025-09-30 | 10-Q | 2025 | 17,276,000,000 | 5,787,000,000 |
| 2025-06-30 | 10-Q | 2025 | 15,806,000,000 | 4,428,000,000 |
| 2025-03-31 | 10-Q | 2025 | 15,529,000,000 | 5,085,000,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 15,624,000,000 | 3,744,000,000 |
| 2024-09-30 | 10-Q | 2024 | 16,657,000,000 | 3,161,000,000 |
| 2024-06-30 | 10-Q | 2024 | 16,112,000,000 | 5,461,000,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.